ArticleEmerging infectious diseases2004
Multidrug-resistant strains of Salmonella enterica Typhimurium, United States, 1997-1998.
Article in Emerging infectious diseases, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Epidemiology and antimicrobial resistance ofInfectious diseases (London, England) · 2026Article
- A Bayesian latent class mixture model with censoring for correlation analysis in antimicrobial resistance across populations.BMC medical research methodology · 2021Article
- Increased Incidence of Antimicrobial-Resistant Nontyphoidal Salmonella Infections, United States, 2004-2016.Emerging infectious diseases · 2021Article
- Article
- Distribution of extended-spectrum β-lactamases (ESBLs) amongIranian journal of microbiology · 2018Article
- Antimicrobial Resistance in Salmonella in the United States from 1948 to 1995.Antimicrobial agents and chemotherapy · 2016Article
- Diversity of multidrug-resistant salmonella enterica strains associated with cattle at harvest in the United States.Applied and environmental microbiology · 2011Article
- Evidence for a second genomic island conferring multidrug resistance in a clonal group of strains of Salmonella enterica serovar Typhimurium and its monophasic variant circulating in Italy, Denmark, and the United Kingdom.Journal of clinical microbiology · 2010Article
- Risk factors for Salmonella Enteritidis and Typhimurium (DT104 and non-DT104) infections in The Netherlands: predominant roles for raw eggs in Enteritidis and sandboxes in Typhimurium infections.Epidemiology and infection · 2006Article
- Multidrug resistance in Salmonella enterica serotype Typhimurium from humans in France (1993 to 2003).Journal of clinical microbiology · 2006Article
- Antimicrobial-drug susceptibility of human and animal Salmonella typhimurium, Minnesota, 1997-2003.Emerging infectious diseases · 2005Article
- Pilot study to evaluate microarray hybridization as a tool for Salmonella enterica serovar Typhimurium strain differentiation.Journal of clinical microbiology · 2005Article
- Hospitalization and antimicrobial resistance in Salmonella outbreaks, 1984-2002.Emerging infectious diseases · 2005Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
To evaluate multidrug-resistant strains of Salmonella enterica serotype Typhimurium, including definitive type 104 (DT104) in the United States, we reviewed data from the National Antimicrobial Resistance Monitoring System (NARMS). In 1997 to 1998, 703 (25%) of 2,767 serotyped Salmonella isolates received at NARMS were S. Typhimurium; antimicrobial susceptibility testing and phage typing were completed for 697. Fifty-eight percent (402) were resistant to > or = 1 antimicrobial agent. Three multidrug-resistant (> or = 5 drugs) strains accounted for (74%) 296 of all resistant isolates. Ceftriaxone resistance was present in 8 (3%), and nalidixic acid resistance in 4 (1%), of these multidrug-resistant strains. By phage typing, 259 (37%) of S. Typhimurium isolates were DT104, 209 (30%) were of undefined type and 103 (15%) were untypable. Fifty percent (202) of resistant (> or = 1 drug) isolates were DT104. Multidrug-resistant S. Typhimurium isolates, particularly DT104, account for a substantial proportion of S. Typhimurium isolates; ceftriaxone resistance is exhibited by some of these strains.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.